The Auditor General has recommended introducing a co-payment system for patients receiving medical treatment abroad under the Aasandha Health Insurance Scheme.
The recommendation comes in a performance audit report on the Social Health Insurance Scheme (SHISS) covering 2019–2024.
The report revealed that the government spent MVR 35 billion on medical treatment during the period, with the cost of Aasandha abroad increasing by an average of 14 percent annually. It highlighted challenges such as rising program costs, the role of referring doctors, and the growing reliance on overseas treatment.
To address these issues, the audit suggested that patients contribute a portion of the cost instead of the state covering the full expense, and recommended increasing patient responsibility for treatment.
The report also urged the development of domestic medical facilities to reduce dependence on foreign hospitals, noting that some cases are still sent abroad due to unimplemented agreements or lack of public confidence in local services.
The recommendation comes in a performance audit report on the Social Health Insurance Scheme (SHISS) covering 2019–2024.
The report revealed that the government spent MVR 35 billion on medical treatment during the period, with the cost of Aasandha abroad increasing by an average of 14 percent annually. It highlighted challenges such as rising program costs, the role of referring doctors, and the growing reliance on overseas treatment.
To address these issues, the audit suggested that patients contribute a portion of the cost instead of the state covering the full expense, and recommended increasing patient responsibility for treatment.
The report also urged the development of domestic medical facilities to reduce dependence on foreign hospitals, noting that some cases are still sent abroad due to unimplemented agreements or lack of public confidence in local services.
